Total Payments
$37,077
2024 Payments
$5,116
Companies
71
Transactions
1,888
Medicare Patients
4,202
Medicare Billing
$391,295
Payment Breakdown by Category
Food & Beverage$31,515 (85.0%)
Other$4,054 (10.9%)
Travel$1,282 (3.5%)
Education$226.01 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $31,515 | 1,857 | 85.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,054 | 11 | 10.9% |
| Travel and Lodging | $1,282 | 6 | 3.5% |
| Education | $226.01 | 14 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Supernus Pharmaceuticals, Inc. | $3,557 | 65 | $0 (2021) |
| Mallinckrodt LLC | $2,752 | 14 | $0 (2018) |
| UCB, Inc. | $2,382 | 132 | $0 (2024) |
| ABBVIE INC. | $2,346 | 159 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,269 | 145 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $2,092 | 147 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,810 | 118 | $0 (2024) |
| EMD Serono, Inc. | $1,484 | 58 | $0 (2024) |
| Allergan, Inc. | $1,315 | 129 | $0 (2022) |
| Genentech USA, Inc. | $1,176 | 55 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,116 | 259 | ABBVIE INC. ($698.28) |
| 2023 | $4,117 | 213 | ABBVIE INC. ($506.34) |
| 2022 | $4,258 | 236 | ABBVIE INC. ($628.06) |
| 2021 | $4,135 | 264 | AbbVie Inc. ($463.31) |
| 2020 | $3,010 | 208 | Allergan, Inc. ($372.69) |
| 2019 | $4,602 | 259 | EMD Serono, Inc. ($545.40) |
| 2018 | $6,608 | 242 | Supernus Pharmaceuticals, Inc. ($3,162) |
| 2017 | $5,231 | 207 | Mallinckrodt LLC ($2,616) |
All Payment Transactions
1,888 individual payment records from CMS Open Payments — Page 1 of 76
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $21.14 | General |
| Category: Neuroscience | ||||||
| 12/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.94 | General |
| 12/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: PAIN | ||||||
| 12/17/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/17/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Neuroscience | ||||||
| 12/17/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/13/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: Rare Disease | ||||||
| 12/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: PAIN | ||||||
| 12/06/2024 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 12/05/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $25.97 | General |
| 12/05/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Neurology | ||||||
| 12/04/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $38.23 | General |
| Category: Neurology | ||||||
| 12/04/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: Neurology | ||||||
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.23 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $16.80 | General |
| Category: NEUROLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Neuropsychiatry | ||||||
| 11/25/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Neuroscience | ||||||
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/22/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Musculoskeletal | ||||||
| 11/21/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 799 | 1,251 | $378,451 | $74,414 |
| 2022 | 20 | 1,002 | 1,524 | $461,251 | $98,555 |
| 2021 | 22 | 1,191 | 1,713 | $491,126 | $112,953 |
| 2020 | 20 | 1,210 | 1,756 | $485,584 | $105,373 |
Total Patients
4,202
Total Services
6,244
Medicare Billing
$391,295
Procedure Codes
82
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 39 | 123 | $52,152 | $12,809 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 140 | $29,400 | $8,509 | 28.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 61 | 63 | $18,018 | $7,987 | 44.3% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 25 | 70 | $35,630 | $5,268 | 14.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 106 | 143 | $26,884 | $4,635 | 17.2% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 38 | 38 | $21,014 | $4,098 | 19.5% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 53 | 53 | $20,617 | $3,921 | 19.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 40 | 40 | $18,840 | $3,643 | 19.3% |
| 64643 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | Office | 2023 | 25 | 68 | $19,924 | $3,226 | 16.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 50 | $5,700 | $2,913 | 51.1% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 71 | 207 | $43,470 | $2,836 | 6.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 32 | $5,035 | $2,791 | 55.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 24 | $6,360 | $2,288 | 36.0% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2023 | 15 | 29 | $14,471 | $2,151 | 14.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 13 | 30 | $15,450 | $2,068 | 13.4% |
| 64642 | Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity | Office | 2023 | 19 | 44 | $19,624 | $2,028 | 10.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,168 | $1,405 | 27.2% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 29 | 52 | $8,164 | $658.68 | 8.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 14 | 14 | $6,230 | $590.52 | 9.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 14 | 14 | $6,300 | $590.52 | 9.4% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 43 | 139 | $58,936 | $14,693 | 24.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 92 | 98 | $28,028 | $13,949 | 49.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 184 | 191 | $40,110 | $11,770 | 29.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 97 | 97 | $29,488 | $8,466 | 28.7% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2022 | 31 | 79 | $40,211 | $5,573 | 13.9% |
About Dr. William Evans, MD
Dr. William Evans, MD is a Clinical Neurophysiology healthcare provider based in Ocean Springs, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619913761.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Evans, MD has received a total of $37,077 in payments from pharmaceutical and medical device companies, with $5,116 received in 2024. These payments were reported across 1,888 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($31,515).
As a Medicare-enrolled provider, Evans has provided services to 4,202 Medicare beneficiaries, totaling 6,244 services with total Medicare billing of $391,295. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Other Specialties Neurology
- Location Ocean Springs, MS
- Active Since 06/20/2006
- Last Updated 05/02/2022
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1619913761
Products in Payments
- TROKENDI XR (Drug) $3,395
- ACTHAR (Biological) $2,812
- NUPLAZID (Drug) $2,092
- BOTOX (Biological) $1,330
- KESIMPTA (Drug) $1,099
- Briviact (Drug) $987.94
- UBRELVY (Drug) $880.61
- APTIOM (Drug) $877.92
- Aimovig (Biological) $822.20
- Vimpat (Drug) $792.21
- OCREVUS (Biological) $735.94
- AJOVY (Drug) $699.99
- GILENYA (Drug) $649.02
- GOCOVRI (Drug) $638.29
- VYEPTI (Biological) $624.06
- QULIPTA (Drug) $614.38
- UPLIZNA (Drug) $613.84
- NURTEC ODT (Drug) $583.80
- NUEDEXTA (Drug) $550.18
- Mavenclad (Biological) $537.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.